Boussard & Gavaudan Holding Limited
Boussard & Gavaudan Holding Limited is a closed-ended balanced fund of funds launched and managed by Boussard & Gavaudan Asset Management, LP. It invests in a fund which invests in public equity and fixed income markets across the globe. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in units of BG Umbrella Fund Plc - BG Fund, a feed… Read more
Boussard & Gavaudan Holding Limited (BGHL) - Net Assets
Latest net assets as of June 2024: €352.15 Million EUR
Based on the latest financial reports, Boussard & Gavaudan Holding Limited (BGHL) has net assets worth €352.15 Million EUR as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€354.23 Million) and total liabilities (€2.08 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €352.15 Million |
| % of Total Assets | 99.41% |
| Annual Growth Rate | -3.91% |
| 5-Year Change | -1.86% |
| 10-Year Change | -42.57% |
| Growth Volatility | 13.25 |
Boussard & Gavaudan Holding Limited - Net Assets Trend (2008–2023)
This chart illustrates how Boussard & Gavaudan Holding Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Boussard & Gavaudan Holding Limited (2008–2023)
The table below shows the annual net assets of Boussard & Gavaudan Holding Limited from 2008 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €342.32 Million | -0.85% |
| 2022-12-31 | €345.25 Million | -5.58% |
| 2021-12-31 | €365.63 Million | +2.29% |
| 2020-12-31 | €357.45 Million | +2.48% |
| 2019-12-31 | €348.81 Million | -46.06% |
| 2018-12-31 | €646.65 Million | -6.15% |
| 2017-12-31 | €689.00 Million | +5.81% |
| 2016-12-31 | €651.17 Million | +4.58% |
| 2015-12-31 | €622.67 Million | +4.47% |
| 2014-12-31 | €596.03 Million | -2.58% |
| 2013-12-31 | €611.84 Million | +6.64% |
| 2012-12-31 | €573.76 Million | +1.42% |
| 2011-12-31 | €565.71 Million | -17.19% |
| 2010-12-31 | €683.17 Million | -1.05% |
| 2009-12-31 | €690.43 Million | +10.94% |
| 2008-12-31 | €622.36 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Boussard & Gavaudan Holding Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 29406076800.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €142.61 Million | 41.66% |
| Common Stock | €199.71 Million | 58.34% |
| Total Equity | €342.32 Million | 100.00% |
Boussard & Gavaudan Holding Limited Competitors by Market Cap
The table below lists competitors of Boussard & Gavaudan Holding Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MEVIS MEDSOL N - Dusseldorf Stock Exchang
DU:M3V
|
$258.06K |
|
The Yumy Candy Company Inc
OTCQB:YUMFF
|
$258.31K |
|
FRIO3F
SA:FRIO3F
|
$258.36K |
|
Prima Moda SA
WAR:PMA
|
$258.58K |
|
UPSD
BATS:UPSD
|
$257.86K |
|
CompuLab Ltd
TA:CLAB
|
$257.82K |
|
ANGLO AMERICAN
MU:NGLB
|
$257.63K |
|
EMPLOYERS HLDNGS
BE:YGB
|
$257.55K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Boussard & Gavaudan Holding Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 345,246,903 to 342,318,616, a change of -2,928,287 (-0.8%).
- Net loss of 2,680,821 reduced equity.
- Share repurchases of 247,466 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-2.68 Million | -0.78% |
| Share Repurchases | €247.47K | -0.07% |
| Total Change | €- | -0.85% |
Book Value vs Market Value Analysis
This analysis compares Boussard & Gavaudan Holding Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.01x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.84x to 1.01x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | €9.75 | €27.70 | x |
| 2009-12-31 | €11.65 | €27.70 | x |
| 2010-12-31 | €13.03 | €27.70 | x |
| 2011-12-31 | €12.90 | €27.70 | x |
| 2012-12-31 | €15.04 | €27.70 | x |
| 2013-12-31 | €16.93 | €27.70 | x |
| 2014-12-31 | €17.19 | €27.70 | x |
| 2015-12-31 | €19.89 | €27.70 | x |
| 2016-12-31 | €22.15 | €27.70 | x |
| 2017-12-31 | €23.44 | €27.70 | x |
| 2018-12-31 | €22.00 | €27.70 | x |
| 2019-12-31 | €12.89 | €27.70 | x |
| 2020-12-31 | €24.67 | €27.70 | x |
| 2021-12-31 | €28.46 | €27.70 | x |
| 2022-12-31 | €27.72 | €27.70 | x |
| 2023-12-31 | €27.56 | €27.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Boussard & Gavaudan Holding Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.78%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: -0.00x
- • Equity Multiplier: 1.01x
- Recent ROE (-0.78%) is below the historical average (3.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -32.11% | 0.00% | -0.30x | 1.06x | €-262.09 Million |
| 2009 | 19.43% | 87.06% | 0.21x | 1.04x | €65.10 Million |
| 2010 | 8.60% | 75.57% | 0.11x | 1.04x | €-9.58 Million |
| 2011 | -3.78% | 0.00% | -0.03x | 1.12x | €-77.53 Million |
| 2012 | 7.19% | 104.02% | 0.06x | 1.12x | €-16.02 Million |
| 2013 | 11.13% | 94.80% | 0.10x | 1.14x | €6.94 Million |
| 2014 | 4.91% | 98.38% | 0.04x | 1.13x | €-30.32 Million |
| 2015 | 12.28% | 99.30% | 0.11x | 1.15x | €14.23 Million |
| 2016 | 6.01% | 95.12% | 0.06x | 1.13x | €-26.01 Million |
| 2017 | 5.49% | 98.25% | 0.05x | 1.12x | €-31.07 Million |
| 2018 | -6.55% | 0.00% | -0.06x | 1.11x | €-107.01 Million |
| 2019 | 5.59% | 97.59% | 0.06x | 1.01x | €-15.36 Million |
| 2020 | 9.43% | 98.11% | 0.09x | 1.03x | €-2.04 Million |
| 2021 | 9.60% | 98.06% | 0.09x | 1.03x | €-1.47 Million |
| 2022 | -5.36% | 0.00% | -0.05x | 1.00x | €-53.04 Million |
| 2023 | -0.78% | 0.00% | 0.00x | 1.01x | €-36.91 Million |
Industry Comparison
This section compares Boussard & Gavaudan Holding Limited's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Boussard & Gavaudan Holding Limited (BGHL) | €352.15 Million | -32.11% | 0.01x | $257.95K |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |